The genetic properties of strain K/2002, isolated from fecal samples of a 7-monthold child who had received his first oral poliovirus vaccine (OPV) dose at the age of 3 months, are described. Preliminary sequencing characterization of isolate K/2002 revealed an S3/S2 recombination event at the 3 0 end of the VP1 coding region.
Introduction
Polioviruses, the causal agent of poliomyelitis, belong to the genus Enterovirus in the family Picornaviridae and are classified into three serotypes (PV1, PV2, PV3). Poliovirus is a nonenveloped positive single-strand RNA virus of c. 7500 bases in length. The poliovirus genome contains a 5 0 -untranslated region (UTR), coding region, 3 0 UTR and poly(A) tail. The structural (VP4, VP2, VP3 and VP1) and nonstructural (2A, 2B, 2C, 3A, 3B, 3C and 3D) viral proteins are produced after translation of the coding region and proteolytic cleavage of the polyprotein (Wimmer et al., 1993) .
Poliovirus capsid consists of 60 protomers. Each capsid protomer is composed of VP1, VP2, VP3 and VP4 capsid proteins (one copy of each). The viral canyon (where receptor CD155 is connected during virus cell entry) and the virus antigenic sites, both important viral structural elements, are situated at the external side of the capsid, which consists of VP1, VP2 and VP3 capsid proteins. VP4 capsid protein is located at the internal side of the capsid (Emini et al., 1982; Hogle et al., 1985) .
There are two vaccines against poliovirus, the inactivated poliovirus vaccine (IPV) and the oral poliovirus vaccine (OPV). OPV is the vaccine of choice against poliomyelitis and consists of live attenuated poliovirus Sabin strains of the three serotypes. OPV has several advantages over IPV, such as: simplicity of administration, induction of mucosal immunity and neutralizing antibodies, and low cost. Furthermore, spread of OPV strains into unimmunized contacts effectively blocks the transmission of wild-type poliovirus in the community (Kew et al., 2005) . However, there are two major drawbacks following OPV use: (1) progeny of the respective OPV strains may evolve into transmissible pathogens (cVDPVs) causing outbreaks of paralytic disease, predominantly in regions with gaps in OPV coverage, and (2) OPV strains have been implicated in rare cases of vaccine-associated paralytic poliomyelitis (VAPP). The most recent outbreaks associated with cVDPV strains were observed in Hispaniola (2000 Hispaniola ( -2001 , the Philippines (2001) and Madagascar (2002) (Kew et al., 2002; Rousset et al., 2003; Shimizu et al., 2004) . The underlying cause of VAPP is the genetic instability of OPV strains, as key substitutions conferring the attenuated phenotype of Sabin strains have been frequently found to be reverted in isolates from VAPP cases (Georgescu et al., 1997; Cherkasova et al., 2005) . VAPP incidents are more frequently associated with Sabin 3 strains (71% of cases) followed by Sabin 2 strains (26% of cases), while a small proportion of reported VAPP cases are associated with Sabin 1 strains (Strebel et al., 1992) .
Poliovirus is characterized by high rates of molecular evolution. Two major mechanisms account for the high rates of poliovirus evolution: mutations and recombination. Mutations are consistent with the high error rate of viral RNA-dependent RNA polymerase, estimated to be c. 10
À4
per base per replication cycle, an error rate that reflects the quasispecies nature of poliovirus (Wimmer et al., 1993) . By contrast, recombination is a very frequent event in poliovirus evolution. Recombination may be considered useful for the virus by elimination of adverse mutations that may have occurred in the viral genome, providing in this way rapid adaptation of the virus to a new environment.
The trivalent nature of OPV provides ideal conditions for intertypic recombination between the attenuated strains of the three poliovirus serotypes. Coinfection of the intestinal cells of a vaccinated person with Sabin 1, Sabin 2 and Sabin 3 strains and the mixed replication complexes locating at few preferential sites in the perinuclear region of the target cells promote intertypic recombination (Egger & Bienz, 2002) . Intertypic recombination between Sabin strains usually takes place at the nonstructural part of the genome and a high proportion of type 2 and type 3 strains isolated from healthy vaccinated individuals and from VAPP patients have been found to be recombinants (Cuervo et al., 2001; Georgopoulou & Markoulatos, 2001; Cherkasova et al., 2002; Karakasiliotis et al., 2004; Paximadi et al., 2006) . According to previous studies, specific types of recombination junctions are located in certain genomic regions. Recombination hotspots are located in the 2C genomic region for recombination junctions of type S3/Sx and in the 3D genomic region for recombination junctions of type S2/Sx (Cuervo et al., 2001; Karakasiliotis et al., 2004; Paximadi et al., 2006) . Natural intertypic capsid recombination between Sabin strains is a very rare phenomenon, possibly due to structural constraints that govern the integrity of capsid shell region. Only two natural intertypic capsid recombinant strains have been isolated thus far and both contained a chimeric S3/S2 VP1 capsid protein and the recombination junction was located at the 3 0 end of VP1 genomic region (Martin et al., 2002; Blomqvist et al., 2003) .
Here we report the isolation of an S3/S2 recombinant strain from stools of a 7-month-old boy. Preliminary characterization of the isolate revealed an S3/S2 recombination junction at the 3 0 end of the VP1 capsid protein. This finding prompted us to study further the genomic and phenotypic properties of the isolate, and complete genomic sequencing and temperature sensitivity tests were performed.
Materials and methods

Virus isolation
The patient was an immunocompetent 7-month-old boy who had received his first OPV dose at the age of 3 months and some days before virus isolation was hospitalized with neutropenia and sudden fever. The virus was isolated in Hep2 cells in December 2002 in Athens, Greece (clinical sample K/2002) from stools of the patient. In order to avoid mixtures of strains, serial 10-fold dilutions were performed. The last dilution in which a complete cytopathic effect (CPE) was observed was passaged again in a 25-cm 2 flask containing Hep2 cells in Eagle's minimal essential medium and 1% fetal calf serum, in order to confirm CPE. The serotype of isolate K/2002 was determined by seroneutralization with rabbit polyclonal antibodies (National Institute for Public Health and the Environment, RIVM, the Netherlands) according to the manufacturer's instructions. The reference strains Sabin 1, Sabin 2 and Sabin 3 were maintained in our laboratory and grown in Hep2 cells.
Preliminary characterization of the isolate
RNA extraction (Casas et al., 1995) , reverse transcription with antisense primers EUC2a and EUC2b, and PCR with primers EUG3a, EUG3b, EUG3c and EUC2 were performed in order to obtain the genomic fragment encompassing from the 3 0 end of VP1 until the first half of the 2C genomic region. PCR products were sequenced at Macrogen Inc. (Seoul, Korea).
Complete genomic sequencing of isolate K/2002
Reverse transcription and PCR reactions for isolate K/2002 were performed with an MJ Research Minicycler. Five microliters of extracted RNA and 2 mL of random d(N6) primers (New England Biolabs) were incubated at 70 1C for 5 min. The reaction mixture for each tube consisted of: 5 mL 5 Â M-MLV reaction buffer, 200 U M-MLV reverse transcriptase (RT; Promega Corp., Madison WI), 5 mL dNTPs (1 mM), 40 U RNAse inhibitor (Promega Corp.) and RNAse-free distilled water up to a final volume of 18 mL. Eighteen microliters of the reaction mixture was added to the annealed template-RNA solution and incubated for 1 h at 37 1C for cDNA synthesis and afterwards at 94 1C for 5 min for M-MLV RT inactivation.
The primer pairs used in this study are shown in Table 1 . Primer pairs S 3 309/S 3 044, S 3 936/S 3 510, S 3 78/S 3 864, S 3 709/ S 3 218 and S 3 40/S 3 659 were designed according to the reference Sabin 3 strain (AY184221). The PRIMER 3 program (http://www.genome.wi.-mit.edu/genomesoftware/other/) was used for design of all primer pairs used in this study.
The PCR mixture for each tube comprised: 3 mL cDNA from isolate K/2002, 2 mL of each primer pair, 5 mL dNTPs (10 mM), 2 mL MgCl 2 (50 mM), 0.5 mL (2.5U) Taq DNA polymerase (Biotaq, Moscow, Russia) and double distilled H 2 O up to a final volume of 50 mL. For primer pairs S 3 309/S 3 044, S 3 936/ S 3 510, S 3 78/S 3 864, S 3 709/S 3 218 and S 3 40/S 3 659, 40 cycles were performed. Each cycle consisted of 20 s of denaturation at 95 1C, 20 s of annealing at 55 1C and 20 s of extension at 72 1C. The final extension step was carried out at 78 1C for 15 min. For all other primer pairs, PCR conditions were as described in the original publications (see Table 1 ). Analysis of PCR products was performed through agarose gel electrophoresis (2% agarose, 1 mg mL À1 ethidium bromide in Tris-boric acid-EDTA buffer) and as a molecular weight marker the ladder HaeIII jX174 (Invitrogen Life Technologies, Paisley, UK) was used. Where necessary, PCR products were cleaned up using a PCR gel extraction kit (Qiagen GmbH, Hilden, Germany). All PCR products were sequenced at Macrogen Inc.
Sequence analysis
CLUSTALW was used for genomic alignment of isolate K/2002 with reference strains Sabin 3 (AY184221) and Sabin 2 (AY184220). For estimation of the age of the isolate, the percentage of mutated synonymous sites among all synonymous sites in the capsid coding region (Ks) was calculated according to the method presented by Li et al. (1985) . Furthermore, the Ks parameter was calculated separately for the VP1 region. Viral age was determined after comparison between the calculated Ks of the capsid coding region of strain K/2002 and the reported Ks for the rate of evolution of the capsid coding region of strain Sabin 3 according to Martin et al. (2000) . For the VP1 region, viral age was calculated after comparison between the calculated Ks of the VP1 region of K/2002 and the reported Ks for the VP1 of Sabin 1 according to Gavrilin et al. (2000) . The amino acid sequence of isolate K/2002 was obtained through GENE-RUNNER v. 3.05, while CLUSTALW was used for amino acid sequence alignment between isolate K/2002 and reference strains Sabin 3 and Sabin 2. Depiction of amino acid substitutions identified in the capsid coding region of isolate K/2002 was based on the capsid protomer structure 1VBE.pdb of poliovirus type 3, Sabin strain, with the use of RASMOL v.2.7.1.1 (http://www.umass.edu/microbio/rasmol; Grant et al., 1994) . 
Nucleotide sequence accession number
The complete genomic sequence of isolate K/2002 was submitted to the GenBank library under accession number EF456707.
Results
Preliminary isolate characterization
Strain K/2002 was isolated from fecal samples of a 7-monthold boy in December 2002, c. 4 months after he had received his first OPV dose. Seroneutralization with rabbit polyclonal antibodies revealed that the isolate was of poliovirus type 3 serotype. Preliminary characterization of the isolate was achieved by sequencing of the genomic region encompassing from the 3 0 end of VP1 until the first half of 2C and revealed that the isolate was of Sabin 3 vaccine origin with an intertypic S3/S2 recombination junction at the 3 0 end of the VP1 coding region. Due to the fact that capsid intertypic recombination is a very rare event, complete genomic sequencing was performed to elucidate further the genetic properties of isolate K/2002.
Genomic sequencing of isolate K/2002
The genomic sequence of isolate K/2002 from nucleotide 41 (Sabin 3 numbering) until nucleotide 7403 (Sabin 2 numbering) was obtained. Alignments of the genomic sequence of isolate K/2002 with the genomic sequences of reference strains Sabin 3 (AY184221) and Sabin 2 (AY18420) revealed several mutations scattered throughout the genome, while no other recombination junction was identified. The mutations identified in the genome of K/2002 are presented in Table 2 .
In the 5 0 UTR, four mutations were identified, three of which were located in the region that contains the conserved RNA secondary structural elements, while the remaining one was located in the hypervariable region. Nucleotides 114 and 190, in which a C ! T transition was identified, are located in single strand regions of domains II and III, respectively. Furthermore, a T ! C nucleotide substitution was identified in nucleotide 472, in direct contrast to the wild-type strain. Nucleotide 472 is located in a double strand region of domain V and the T ! C transition in this position is concomitant with loss of the attenuated phenotype of Sabin 3 strains (Westrop et al., 1989) .
The mutational pattern of the capsid coding region was characterized by a preponderance of synonymous vs. nonsynonymous mutations. Specifically, of the 12 mutations identified, 11 were synonymous and only one resulted in amino acid substitution. In the VP2 capsid protein, two synonymous mutations were identified as well as in VP3.
The vast majority of nucleotide substitutions identified in the capsid were localized in the VP1 capsid protein. Seven nucleotide substitutions that resulted in no amino acid change were found, while only one mutation, at position 2493 (C ! T), resulted in amino acid substitution. Specifically, the C ! T transition of nucleotide 2493 led to substitution of residue 6 of VP1 from threonine to isoleucine. Amino acid 6 of VP1 is located at the amino-terminus of VP1, in the capsid interior.
Furthermore, a recombination event was identified at the 3 0 end of the VP1 genomic region. Specifically, a Sabin 3/ Sabin 2 recombination junction located at nucleotide region 3275-3285 was identified (Fig. 1a and b) . The recombination event led to the introduction of six Sabin 2 amino acids at the corresponding positions of the Sabin 3 VP1 region ( Fig. 2a and b) . The amino acid substitutions were located at VP1 positions 279 (Phe ! Tyr), 286 (Arg ! Lys), 287 (Asn ! Asp), 288 (Asn ! Gly), 290 (Asp ! Thr) and 293 (Ser ! Pro). Residues 286, 287, 288 and 290 are located at the capsid exterior and comprise antigenic site IIIa (Minor et al., 1986) . Amino acid 293 is included in the binding site of the poliovirus receptor CD155 (Belnap et al., 2000) . Specifically, amino acid 293 is part of a region (amino acids 293-297) which is in contact with the N-terminal end of the D strand and the C-terminal end of the E strand of the virus receptor, during virus entry into the cell (Belnap et al., 2000) . Furthermore, residue 279 is highly exposed in the outer surface of the virion and is in close proximity to residue 290, as revealed using the RASMOL program (Fig. 1b) .
At the Sabin 2 part of the K/2002 genome, mostly synonymous mutations were identified in almost all the nonstructural proteins. Two mutations resulted in amino acid substitutions, at nucleotide 4613 (T ! A), that resulted in a Phe ! Tyr change in residue 164 of 2C and a A ! G transition at nucleotide 6257 that resulted in an Asn ! Ser substitution in residue 91 of 3D polymerase. The structural and functional importance of these residues is not known.
Age of isolate K/2002
According to previous studies (Kew et al., 1998; Bellmunt et al., 1999; Gavrilin et al., 2000; Martin et al., 2000) the rate of accumulation of synonymous substitutions in naturally evolving polioviruses has a linear character. A reliable estimation of the viral age is feasible if calculations are based on synonymous mutations in the VP1 genomic region (Cherkasova et al., 2002) . The percentage of mutated synonymous sites among all synonymous sites per year (Ks) for the VP1 region of poliovirus Sabin 1 strain is 3.28% according to Gavrilin et al. (2000) . The Ks for the VP1 genomic region of isolate K/2002 was 3.02%. As a consequence of the linear character of accumulation of synonymous mutations, the age of isolate K/2002 was deduced to be c. 11 months based on calculations for the VP1 region. The Ks for the capsid coding region was 0.8%. The reported Ks for the capsid coding region of Sabin 3 is 3.4% according to Martin et al. (2000) . As a result, the age of the isolate, based on calculations for the capsid coding region, is c. 12 weeks.
RCT marker test
The RCT marker assay revealed that isolate K/2002 had lost temperature sensitivity. Specifically, the titer of isolate K/2002 was the same at 36 and 39.5 1C (2 logTCID 50 / 0.1 mL). This means that replication efficiency of isolate K/ 2002 remains the same even at elevated temperatures. For the reference strain Sabin 3 the difference between titers at 36 1C (3.5 logTCID 50 /0.1 mL) and at 39.5 1C (1.3 logT-CID 50 / 0.1 mL) was 42 logarithms, a result consistent with the temperature-sensitive phenotype of Sabin strains.
Discussion
We have described the isolation and complete genomic sequence characterization of a natural intertypic capsid recombinant poliovirus strain. Strain K/2002 was isolated from a 7-month-old boy, 16 weeks following his first OPV dose. Preliminary sequencing characterization of the isolate revealed an S3/S2 recombination junction at the UTR  114  C  T  190  C  T  472  T  C  658  A  G  VP2  1228  A  C  1672  T  C  VP3  2047  G  A  2153  C  T  VP1  2493  C  T  6  Thr  Ile  2593  A  G  2770  G  T  2977  A  G  3073  A  G  3118  A  G  3265  A  G  3274  T  A  Sabin 2  2B  4056  C  T  2C  4308  C  T  4611  C  T  4613  T  A  164  Phe  Tyr  3A  5364  G  A  3C  5949  G  A  3D  6144  C  T  6257  A  G  91  Asn  Ser  6609  T  C  7002 T C Nucleotide and amino acid positions are with reference to Sabin 3 (AY184221) until the end of the VP1 region. From the 2B region until the end of the genome, nucleotide and amino acid positions are according to Sabin 2 (AY184220).
3 0 end of the VP1 region, which resulted in the introduction of six Sabin 2 amino acids in a Sabin 3 genomic background.
Natural intertypic recombination among Sabin strains in the capsid region is a very rare event. Thus far only two natural intertypic capsid recombinants have been isolated (Martin et al., 2002; Blomqvist et al., 2003) . Taking into consideration the rarity of a capsid recombination event and the fact that in all capsid recombinants isolated thus far recombination junctions were located at the same region and were of the same type, we can hypothesize that the 3 0 end of VP1 may be a preferential 'hotspot' for the occurrence of S3/S2 recombination events. This hypothesis is reinforced by the nonrandom distribution of certain types of recombination events in specific regions of the poliovirus genome. Bias towards the localization of certain types of recombination junctions in specific genomic regions has been frequently described in previous studies, which have shown that recombination events of the S3/Sx type have been found to occur predominantly in the 2C genomic region, while recombination events of type S2/Sx have been found to occur predominantly in the 3D region (Cuervo et al., 2001; Karakasiliotis et al., 2004; Paximadi et al., 2006) .
There are certain conformational constraints that govern the capsid region and that possibly restrict enrichment of intertypic recombinants with chimeric capsid proteins (Blomqvist et al., 2003) . In isolate K/2002 the inserted amino acids are localized in a region highly exposed in the capsid exterior, in a b-barrel loop of VP1, where the capsid integrity constraints are probably looser. In addition, the majority of amino acids that changed due to the recombination event were replaced by residues with similar properties. The conservative nature of amino acid substitutions can probably be attributed to the overlapping between the regions where viral antigenic sites are located and the region where the virus receptor attaches during virus cell entry (Colston & Racaniello, 1995; Harber et al., 1995; Belnap et al., 2000; He et al., 2000) . Furthermore, most of the amino acid substitutions that occurred by recombination in our isolate have been found to occur through nonsynonymous mutations in isolates of previous studies (Blomqvist et al., 2004; Yanovenko et al., 2006) . This was the case in particular for residues 286, 287, 288, 290 and 293. Owing to the fact that these residues have been found to change in different evolving lineages of Sabin 3 strains, we suggest that the recombination event, which had as a consequence amino acid substitutions at these sites, may confer a selective advantage to replication of the virus. Mutations in two nucleotides, which have been correlated with reversion of the attenuated phenotype of the Sabin 3 strain, were identified. Specifically, transition in nucleotide 472 is a direct reversion towards the neurovirulent progenitor of Sabin 3, P3/Leon/USA/37. The T ! C substitution restores the local secondary structure in domain V of the internal ribosome entry site (IRES), resulting in enhanced binding of polypyrimidine tract binding protein (PTB) and thereby leading to efficient virus translation (Guest et al., 2004) . Furthermore, transition C ! T at nucleotide 2493, which resulted in a threonine to isoleucine substitution of residue 6 of VP1, was identified. Mutation at position 2493 is concomitant with increased neurovirulence. The threonine to isoleucine substitution probably strengthens the hydrophobic interactions between the VP1 amino terminus and endosomal cell membranes during virus cell entry (Fricks & Hogle, 1990; Tatem et al., 1992) .
One of the most important features of this study is the discrepancy between the calculations of the age of isolate K/2002 based on VP1 and that based on the entire capsid coding region. More specifically, the VP1-based age of K/2002 is 11 months while that based on the capsid coding VP1aa_S3  LAVRVVNDHNPTKVTSKVRIYMKPKHVR VWCP RPPRAVPYYGPGVDYRNNLDPLSEKGLT 298  VP1aa_IK  LAVRVVNDHNPTKVTSKVRIYMKPKHVR VWCP RPPRAVPYFGPGVDYKDGLTPLPEKGLT 298  VP1aa_S2 LAVRVVNDHNPTRLTSKIRVYMKPKHVR VWCP RPPRAVPYFGPGVDYKDGLTPLPEKGLT 299 ************::***:*:******** **** ********:******::.* **.***** For visualization, the protomer structure 1VBE.pdb of poliovirus strain Sabin 3 was used (Grant et al., 1994) .
region is c. 12 weeks. Strain K/2002 was isolated 16 weeks after the boy had received his first OPV dose and as a consequence the latter age is closer to the real age of the virus.
In addition, we should also take into consideration the nonuniformity of distribution of mutations in the capsid coding region. More specifically, eight out of the 12 mutations that we identified in the capsid coding region were located in the VP1 capsid protein region, while only four were identified in the remaining capsid regions. This nonuniformity in the distribution of mutations in the capsid coding region could involve another intratypic recombination event between two Sabin 3-derived polioviruses with different degrees of evolutionary divergence. Another scenario for the nonuniform distribution of mutations in the capsid region could be that the recombination event triggered a hypermutation rate in the VP1 region in order to compensate for any possible decrease in fitness.
One of the major advantages of oral poliovirus vaccine is that OPV strains have the capacity to spread to unimmunized individuals, effectively blocking the transmission of wild-type poliovirus in a given community. However, this advantage has proved to be a drawback, as it was the underlying cause of recent cVDPV outbreaks in regions with gaps in OPV coverage (Kew et al., 2002; Rousset et al., 2003; Shimizu et al., 2004) .
The results of the present study as well as the results of previous studies (Cherkasova et al., 2002; Karakasiliotis et al., 2005) highlight the importance of the presence of vaccine-derived viruses that have been produced since the introduction of OPV administration, before planning for strategies that involve cessation of OPV vaccination.
